Australia's BCAL Diagnostics rises on partnership with Sonic Healthcare's unit

BCAL Diagnostics

27/08/2025 06:37

** Shares of BCAL Diagnostics BDX.AX rise 12.5% at A$0.063

** Stock rose as much as 23.2% to A$0.069 earlier in the day, its highest level since July 21

** Medical equipment supplier partners with Sonic Healthcare Australia Pathology, a part of Sonic Healthcare SHL.AX, to advance patient access to BCAL's blood-based cancer diagnostic test

** Over 908,000 shares change hands vs its 30-day avg of 121,482 shares

** Stock is down 35.1% YTD, including the session's moves

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))